Erschienen in:
01.06.2008 | Brief Report
A serosurvey of Anaplasma phagocytophilum in blood donors in Crete, Greece
verfasst von:
D. Chochlakis, A. Papaeustathiou, G. Minadakis, A. Psaroulaki, Y. Tselentis
Erschienen in:
European Journal of Clinical Microbiology & Infectious Diseases
|
Ausgabe 6/2008
Einloggen, um Zugang zu erhalten
Excerpt
Human granulocytic anaplasmosis is a tick-borne infectious disease caused by
Anaplasma phagocytophilum. The disease was first described in the USA in 1994 [
1]; in Europe, the first case was described in 1995, in Slovenia, and since then clinical cases have been reported in France, Holland, Spain, Poland, Austria, and Sweden [
2]. The bacterium has been detected in
Ixodes ricinus ticks in many European countries [
2] with a prevalence ranging from 2% to 45%. A number of seroepidemiological studies have been conducted in Europe [
2];
Anaplasma phagocytophilum has been studied in the past, in blood donors, in Macedonia (North Greece) revealing a 7.3% prevalence of antibodies to
A. phagocytophilum [
3]. The aim of this study was to estimate the seroprevalence of
A. phagocytophilum among blood donors in Crete, Greece, over the period of a year. …
